N/A N=154 Young Men and Media Study
Sexual Behavior
Primary: Study Feasibility Based on the Overall Recruitment Rate — 36.5 overall recruitment rate
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=8 Alcohol and Sex Risk Intervention for MSM Supplement
Heavy Drinking and Sexual Risk Behavior
Primary: Intervention Satisfaction Scale — 4.25 units on a scale
Phase 2 N=30 Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM
Substance Abuse · HIV Infections
Primary: Feasibility: Proportion of Persons Screened Who Are Eligible and Enrolled — 30 Eligible persons screened who enrolled
Phase 2 N=120 Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)
Binge Drinking · HIV
Primary: Binge Drinking Days Per Week — 1.056; 1.722 days per week
N/A N=100 HIV Self-testing With Online Supervision for Vietnamese MSM
HIV
Primary: HIV Self-testing With Online Supervision Past 6 Months at Baseline — 50; 44 Participants
Phase 2 N=58 Pre-Exposure Prophylaxis in YMSM
HIV
Primary: Actual Number of Study Visits Completed by 24 Weeks — 3.5927; 4.6263; 4.6374 Visits — p=0.6983
Phase 2 N=60 Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Substance Abuse · HIV Infections
Primary: Change in Number of Positive Methamphetamine Urine Tests, Comparing Baseline (Week 0) to Final Visit (Week 12). — 40; 6 Percentage reduction
Phase 2 N=60 Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
Methamphetamine Use Disorder
Primary: Number of People With Meth-positive Urine Tests at Weekly Visits — 20; 13; 23; 9 Participants
Phase 2 N=53 Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men
Amphetamine-Related Disorders · HIV · HIV Infections
Primary: Self-reported Methamphetamine Use in Previous 30 Days. — 1.6 days
N/A N=40 mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
HIV Infections · Sexually Transmitted Diseases, Viral · Syphilis
Primary: The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus — 12 Participants
N/A N=24 MI With Text Messaging to Reduce Sexual Risk and Hazardous Drinking Among MSM
Alcohol; Harmful Use · Sex, Unsafe
Primary: Number of Heavy Drinking Episodes NIAAA Criteria (5 or More Drinks on a Single Occasion) — 3.09; 5.33 heavy drinking episodes — p=.048
N/A N=83 Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
HIV Infections
Primary: Illicit Drug Use Days — 3.17; 3.10; 3.25; 2.86 Number of Days — p=0.35
N/A N=1,014 GonoScreen: Efficacy of Screening STIs in MSM
Neisseria Gonorrhoeae Infection · Chlamydia Trachomatis Infection
Primary: Incidence Rate of Ng Plus Ct Detected at Any Site Whilst Individuals Are Screened vs. Not Screened — 0.155; 0.205 Ng or CT cases per study visit
N/A N=115 Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)
HIV
Primary: Retention in the Cohort — 88; 84; 87 Participants
Phase 2 N=338 Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM
HIV Infections · Sexually Transmitted Diseases
Primary: Any Unprotected Anal Intercourse (UAI) With Casual Partners — 2.0; 6.2 Number of episodes — p=< 0.05
N/A N=86 Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color
Substance Use · Sexual Risk
Primary: Illicit Drug Use Days — 3.04; 11.62; 2.00; 6.04 days — p=.19
N/A N=119 A Pilot Peer Mentor Intervention That Trains Black Men Who Have Sex With Men (BMSM) to Use and Promote Uptake of HIV/STI Self-Testing to Peers and Sex Partners: STAR Study (Self-Testing at Your Residence)
HIV/AIDS · Sexually Transmitted Diseases
Primary: Session Attendance — 64; 55 Participants
N/A N=609 Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination
Anus Neoplasms
Primary: Willingness to Receive the Human Papillomavirus (HPV) Vaccine — 338 Participants
N/A N=673 ANCHORS Study: UH2 Project
HIV-1-infection
Primary: Quantity of Alcohol Consumption — 11.38; 7.81; 4.78 drinks
N/A N=188 Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care
Alcohol Drinking · HIV
Primary: Average Number of Drinks Per Week at 6 Months — 13.3; 14.9; 7.5; 5.0 number of drinks
N/A N=286 Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM
Methamphetamine Abuse · HIV
Primary: Methamphetamine Use — 11.13; 10.75; 10.34; 7.79 Days Used in the Past 30 Days — p=0.3137
N/A N=118 Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men
Human Immunodeficiency Virus
Primary: Number of Participants With Self-reported Self-administration of HIV Testing — 46; 44 Participants
N/A N=96 Addressing Psychosocial Needs and HIV Risk in Indian MSM
HIV/STI Risk · HIV/STI Incidence
Primary: Changes in HIV Risk Taking Behavior - Number of Condomless Sex Acts Per Participant — 7.58; 3.69 number of unprotected sex acts — p=<.001
N/A N=401 A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults
HIV
Primary: Proportion of Participants With an Undetectable HIV Viral Load — 107; 113 Participants
Phase 2 N=170 Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
HIV Seroconversion · Stimulant Abuse
Primary: Time From Exposure to Truvada Initiation — 32.8; 33.0 hours
N/A N=54 Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Human Immunodeficiency Virus
Primary: Number of Participants With PrEP Adherence — 45 Participants
Phase 1 N=41 Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
HIV Infections · Depression
Primary: The Number of Sexual Partners in Unprotected Anal Intercourse Reported at 6 Months Minus the Number Reported at Enrollment. — -2.5; -4 Sexual partners — p=0.9
N/A N=2,665 Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
HIV Infection
Primary: Frequency of HIV Testing by Internet-recruited MSM. — 777; 215 Participants
Phase 4 N=16 Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
HIV/AIDS · Substance Use Disorders · Adherence, Medication
Primary: Feasibility of Digital Pills to Measure PrEP Adherence — 411; 368; 320 Expected ingestions per pill counts
N/A N=901 Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men
HIV · Gonorrhea · Chlamydia
Primary: Participants Self-Reporting Condomless Anal Sex at Baseline and 3 Months — 304; 312; 148; 184 Participants — p=0.20